Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.
Jeff McCombs, PhD
Advertisement
Articles by Jeff McCombs, PhD
Advertisement
Latest Updated Articles
Medication Persistence and Its Impact on Type 2 DiabetesPublished: April 1st 2024 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Survey Reveals Clinician Confidence Around Using AI in PA Process
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
